Altshuler Shaham LTD Repligen Corp Transaction History

Altshuler Shaham LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $35,352 - $44,346	-196 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $2,813 - $3,924	19 Added 10.73%	196 $38,000
Q3 2020 Nov 10, 2020	BUY	$122.51 - $158.27 $2,450 - $3,165	20 Added 12.74%	177 $26,000
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $14,809 - $22,055	157 New	157 $19,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.